
Pfizer Inc.
PFE 25.53 (0.00%) 0.00
144.68(B)
Health Care
Pharmaceuticals
Holdings:
Shares:
Cost basis:
Pfizer Inc. (PFE) price target and intrinsic value estimate
PFE's fair price estimate is $35.7
This valuation is based on a fair P/E of 12.8 and EPS estimates of $2.80
The median analyst price target for PFE is $30.5.
Analyst price targets range from $25.0 to $42.0
Is PFE overvalued or undervalued?
PFE is currently trading at $25.53
PFE is undervalued by 29% using the pevaluation method.
PFE is undervalued by 16% compared to median analyst price targets.
Do you agree with this valuation?
Valuation
PEvaluation
Current price
$25.53
Undervalued
Low
$26.8
Median
$35.7
High
$44.7
Fair P/E
Margin of safety
Analyst valuation
Current price
$25.53
Fairly valued
Low
$25.0
Median
$30.5
High
$42.0
Discounted cash-flow
N/A
Negative FCF or FCF estimates
Negative FCF or FCF estimates
Discount
rate10%
rate10%
Terminal
rate5%
rate5%
Growth p.
length5y
length5y
Growth p.
rate10%
rate10%
Economic moat: Wide
Overview
Market data
Market cap:$144.68(B)
Enterprise value:$202.94(B)
Total Equity:$92.56(B)
Shares outstanding:5.67(B)
Div. yield:6.58%
P/S:2.27
P/E:17.98
P/FCF:N/A
P/B:1.57
EPS:$1.4
FCF per share:$0.0
Dividend per share:$1.7
Income (TTM)
Revenue$63.63(B)
Gross profit$47.21(B)
EBITDA$23.27(B)
Net income$8.03(B)
Gross margin74.2%
Net margin12.6%
Balance sheet
Total assets$0
Total liabilities$0
Cash & Short-term inv.$9.95(B)
Long-term debt$0
Debt issued$0
Debt repaid$0
Cash flow (TTM)
FCF$0
CapEx$0
Dividends paid$0
Stock issued$0
Stock repurchased$0
Stock-based comp.$0
Future Growth
Revenue
CAGR: -2.3%FY+1$63.00(B)
FY+2$63.21(B)
FY+3$62.24(B)
FY+4$60.26(B)
FY+5$57.38(B)
Net Income
CAGR: -1.7%FY+1$16.94(B)
FY+2$17.52(B)
FY+3$17.53(B)
FY+4$16.75(B)
FY+5$15.82(B)
EPS
CAGR: -2.2%FY+1$2.95
FY+2$3.06
FY+3$3.05
FY+4$2.89
FY+5$2.70
FCF per share
CAGR: 11.1%FY+1$2.70
FY+2$3.00
Similar Companies
Historical Financials
Showing limited histrical data. Access 10+ years of financials now! Upgrade
Income
RevenueNet IncomeCOGSGross ProfitTotal OpEx.R&DSG&AOperating IncomeInterest ExpenseInterest IncomePre-tax incomeIncome tax
Cash flow
FCFCFONet IncomeD&AStock-based Comp.CFFStock IssuedStock RepurchasedDebt IssuedDebt RepaidDividend PaidCFIAcquisitionsDivestituresCapital Expenditures
Balance sheet
Total AssetsTotal LiabilitiesCurrent assetsCash and EquivalentsShort-term investmentsInventoriesReceivablesNon-current assetsNet PP&EGoodwillCurrent liabilitiesAccounts payableNon-current liabilitiesLong-Term DebtTotal Equity
Shares outstanding
Shares (Basic)Shares (Diluted)
Per share data
EPS (Basic)EPS (Diluted)FCF/ShareDividend/ShareBook value/Share
Ratios
P/EP/FCFP/BP/SEV/EarningsEV/FCFDebt/EquityPayout ratio
Margins
Net Income MarginOperating MarginGross MarginEBITDA MarginFCF Margin
Returns
ROICROAROCEROE
Market Cap.
Market Cap.